David Dodd

David A. Dodd is the founder of RiversEdge BioVentures LLC, established in 2009, where the title held is Chief Executive Officer.
Current jobs include Chairman, President & Chief Executive Officer at GeoVax Labs, Inc. since 2018, and Chief Executive Officer at Vaxygen Holdings LLC.
Former jobs include President, Chief Executive Officer & Director at Serologicals Corp.
from 2000 to 2006; Chief Executive Officer & Director at Medizone International, Inc. from 2017 to 2018; Chairman, President & Chief Executive Officer at BioReliance Corp.
from 2007 to 2009; President & Chief Executive Officer at Solvay Pharmaceuticals, Inc. from 1995 to 2000; Chairman at Unimed Pharmaceuticals LLC from 1999 to 2000; Non-Executive Chairman at Stem Cell Sciences Plc from 2006 to 2009; Chairman at American Foundation for Suicide Prevention; Chairman at Center for Global Health Innovation, Inc.; Director at Æterna Zentaris, Inc. from 2017 to 2018; Director at Sierra Leone Diamond Co. Ltd. from 2006 to 2007; Non-Executive Director at Stheno Corp.; Director at PNP Therapeutics, Inc.; Director at Aruna Bio, Inc.; Principal at Abbott Laboratories; Principal at Bristol Myers Squibb Co.; Member-Management Board at Solvay SA; Principal at Wyeth-Ayerst Laboratories.
Education includes undergraduate degree conferred in 1971 and graduate degree conferred in 1977, both from Georgia State University.